Trabectedin 1 MG [Yondelis]: Clinical Trials

1 trial of Trabectedin 1 MG [Yondelis], newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow Trabectedin 1 MG [Yondelis]: new trials by email Literature Review of Trabectedin 1 MG [Yondelis] trials Research Report on Trabectedin 1 MG [Yondelis]

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
SARC037: A Phase I/II Study to Evaluate the Safety of Trabectedin in Combination With Irinotecan in Ewing Sarcoma Patients
Trabectedin 1 MG [Yondelis], Irinotecan, tumor biopsy - Ewing Sarcoma
Phase 1 / Phase 2CompletedSarcoma Alliance for Research through Collaboration372021-01-052025-12-17

Conditions studied

Sarcoma, Ewing (1)

Sponsors

Sarcoma Alliance for Research through Collaboration (1)

Countries

United States (1)

Top investigators

John Glod, MD/PhD (1)  ·  Patrick Grohar, MD/PhD (1)

Results publications

PMID 41991689

NIH funding

U01CA236220 (1)